Terence J. Quinn
A5053134192- Acute Ischemic Stroke Management
- Stroke Rehabilitation and Recovery
- Dementia and Cognitive Impairment Research
- Frailty in Older Adults
- Health Systems, Economic Evaluations, Quality of Life
- Cerebrovascular and Carotid Artery Diseases
- Intensive Care Unit Cognitive Disorders
- Neurological Disorders and Treatments
- Geriatric Care and Nursing Homes
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Neurological Disease Mechanisms and Treatments
- Chronic Disease Management Strategies
- Nutrition and Health in Aging
- Clinical practice guidelines implementation
- Traumatic Brain Injury and Neurovascular Disturbances
- Blood Pressure and Hypertension Studies
- Gout, Hyperuricemia, Uric Acid
- Meta-analysis and systematic reviews
- Health disparities and outcomes
- Thyroid Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment
- Intracerebral and Subarachnoid Hemorrhage Research
- COVID-19 and healthcare impacts
- Cerebrovascular and genetic disorders
University of Glasgow
2016-2025
University of Edinburgh
2012-2024
University of Bristol
2024
Glasgow Royal Infirmary
2015-2024
University of Liverpool
2021-2024
Population Health Research Institute
2024
McMaster University
2024
Aneurin Bevan University Health Board
2024
Chemical Synthesis Lab
2023
NHS Greater Glasgow and Clyde
2012-2023
Abstract Increasing evidence recognizes Alzheimer's disease (AD) as a multifactorial and heterogeneous with multiple contributors to its pathophysiology, including vascular dysfunction. The recently updated AD Research Framework put forth by the National Institute on Aging–Alzheimer's Association describes biomarker‐based pathologic definition of focused amyloid, tau, neuronal injury. In response this article, here we first discussed that dysfunction is an important early event in...
The use of levothyroxine to treat subclinical hypothyroidism is controversial. We aimed determine whether provided clinical benefits in older persons with this condition.
Abstract Background C-reactive protein (CRP) is a non-specific acute phase reactant elevated in infection or inflammation. Higher levels indicate more severe and have been used as an indicator of COVID-19 disease severity. However, the evidence for CRP prognostic marker yet to be determined. The aim this study examine response patients hospitalized with determine utility on admission predicting inpatient mortality. Methods Data were collected between 27 February 10 June 2020, incorporating...
The immediate and longer-term effects of hemodialysis on cerebral circulation, structure, cognitive function are poorly understood.In a prospective observational cohort study 97 adults (median age 59 years) receiving chronic hemodialysis, we used transcranial Doppler ultrasound to measure arterial mean flow velocity (MFV) throughout dialysis. Using well validated neuropsychological protocol, assessed during off dialysis after 12 months treatment. We also brain magnetic resonance imaging...
Abstract Introduction Increased mortality has been demonstrated in older adults with coronavirus disease 2019 (COVID-19), but the effect of frailty unclear. Methods This multi-centre cohort study involved patients aged 18 years and hospitalised COVID-19, using routinely collected data. We used Cox regression analysis to assess impact age, delirium on risk inpatient mortality, adjusting for sex, illness severity, inflammation co-morbidities. ordinal logistic Clinical Frailty Scale (CFS)...
The optimal management of post-stroke cognitive impairment (PSCI) remains controversial. These joint European Stroke Organisation (ESO) and Academy Neurology (EAN) guidelines provide evidence-based recommendations to assist clinicians in decision making regarding prevention, diagnosis, treatment prognosis.Guidelines were developed according the Grading Recommendations, Assessment, Development Evaluation (GRADE) methodology. working group identified relevant clinical questions, performed...